Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alfred Rademaker

Showing results (181-190 of 226) with videos related to

Pageof 23
Sort By:
Brain Pathology (Zurich, Switzerland)|August 26, 2019
Neuropathologic basis of in vivo cortical atrophy in the aphasic variant of Alzheimer's diseaseDaniel T Ohm, Angela J Fought, Alfred Rademaker, et al.
Cancer Biology & Therapy|November 20, 2009
Reevaluating cathepsin D as a biomarker for breast cancer: serum activity levels versus histopathologyDaniel E Abbott, Naira V Margaryan, Jacqueline S Jeruss, et al.
Archives of Dermatology|August 18, 2010
In situ photoimmunotherapy: a surgery- and limb-sparing approach to the treatment of cutaneous metastases in advanced melanomaStephanie A St Pierre, Jenneé Rommel, Ana Ciurea, et al.
Journal of Neuro-Oncology|January 23, 2014
A phase II trial of PTK787/ZK 222584 in recurrent or progressive radiation and surgery refractory meningiomasJeffrey J Raizer, Sean A Grimm, Alfred Rademaker, et al.
Acta Neuropathologica|May 9, 2019
Revisiting the utility of TDP-43 immunoreactive (TDP-43-ir) pathology to classify FTLD-TDP subtypesYasushi Nishihira, Tamar Gefen, Qinwen Mao, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 13, 2003
Soluble epidermal growth factor receptor (sEGFR/sErbB1) as a potential risk, screening, and diagnostic serum biomarker of epithelial ovarian cancerAndre T Baron, Elsa M Cora, Jacqueline M Lafky, et al.
The American Journal of Gastroenterology|July 9, 2014
Physician assessment and management of complex colon polyps: a multicenter video-based survey studyA Aziz Aadam, Sachin Wani, Charles Kahi, et al.
British Journal of Haematology|December 17, 2016
The impact of fertility preservation on treatment delay and progression-free survival in women with lymphoma: a single-centre experiencePamela B Allen, Mary Ellen Pavone, Kristin N Smith, et al.
Pediatric Blood & Cancer|March 24, 2022
Obesity in children with acute promyelocytic leukemia: What is its prevalence and prognostic significance?Kathryn L Laurie, Paul Lee, Alfred Rademaker, et al.
Breast Cancer Research and Treatment|October 31, 2007
alphaB-crystallin is a novel predictor of resistance to neoadjuvant chemotherapy in breast cancerOlga Ivanov, Feng Chen, Elizabeth L Wiley, et al.
Pageof 23

Showing results (181-190 of 226) with videos related to

Sort By:
Pageof 23
Brain Pathology (Zurich, Switzerland)|August 26, 2019
Neuropathologic basis of in vivo cortical atrophy in the aphasic variant of Alzheimer's diseaseDaniel T Ohm, Angela J Fought, Alfred Rademaker, et al.
Cancer Biology & Therapy|November 20, 2009
Reevaluating cathepsin D as a biomarker for breast cancer: serum activity levels versus histopathologyDaniel E Abbott, Naira V Margaryan, Jacqueline S Jeruss, et al.
Archives of Dermatology|August 18, 2010
In situ photoimmunotherapy: a surgery- and limb-sparing approach to the treatment of cutaneous metastases in advanced melanomaStephanie A St Pierre, Jenneé Rommel, Ana Ciurea, et al.
Journal of Neuro-Oncology|January 23, 2014
A phase II trial of PTK787/ZK 222584 in recurrent or progressive radiation and surgery refractory meningiomasJeffrey J Raizer, Sean A Grimm, Alfred Rademaker, et al.
Acta Neuropathologica|May 9, 2019
Revisiting the utility of TDP-43 immunoreactive (TDP-43-ir) pathology to classify FTLD-TDP subtypesYasushi Nishihira, Tamar Gefen, Qinwen Mao, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 13, 2003
Soluble epidermal growth factor receptor (sEGFR/sErbB1) as a potential risk, screening, and diagnostic serum biomarker of epithelial ovarian cancerAndre T Baron, Elsa M Cora, Jacqueline M Lafky, et al.
The American Journal of Gastroenterology|July 9, 2014
Physician assessment and management of complex colon polyps: a multicenter video-based survey studyA Aziz Aadam, Sachin Wani, Charles Kahi, et al.
British Journal of Haematology|December 17, 2016
The impact of fertility preservation on treatment delay and progression-free survival in women with lymphoma: a single-centre experiencePamela B Allen, Mary Ellen Pavone, Kristin N Smith, et al.
Pediatric Blood & Cancer|March 24, 2022
Obesity in children with acute promyelocytic leukemia: What is its prevalence and prognostic significance?Kathryn L Laurie, Paul Lee, Alfred Rademaker, et al.
Breast Cancer Research and Treatment|October 31, 2007
alphaB-crystallin is a novel predictor of resistance to neoadjuvant chemotherapy in breast cancerOlga Ivanov, Feng Chen, Elizabeth L Wiley, et al.
Pageof 23